Posts

New Thinking on Burnout – Asrar Qureshi’s Blog Post #1314

Image
New Thinking on Burnout – Asrar Qureshi’s Blog Post #1314 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1314 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Ron Lach Preamble This post is inspired by ideas from Scott H. Young article. Link at the end. Why Loving Your Work Can Sometimes Make You More Vulnerable To Burnout We usually think of burnout as something that happens to people who hate their jobs. The logic seems obvious. If work is exhausting, unrewarding and unpleasant, eventually a person will become emotionally and physically depleted. But what if the opposite can also be true? What if the people most passionate about their work can sometimes be especially vulnerable to burnout? That is the intriguing paradox explored by Scott Young in his recent essay The Paradox of Burnout. Young points out that ...
Post a Comment
Read more

Conditional Approval and Pricing of New Drugs – Asrar Qureshi’s Blog Post #1313

Image
Conditional Approval and Pricing of New Drugs – Asrar Qureshi’s Blog Post #1313 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1313 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Pavel Danilyuk Preamble This post is based on INSEAD research by Professor Stephen E. Chick. This is a provocative research which answers and raises several questions.Link at the end. The Real Cost of Health Innovation: Who Pays for Life-Saving Breakthroughs? A new medicine can take more than a decade to reach a patient. It may require billions of dollars of investment, years of laboratory research, multiple stages of clinical trials and increasingly complex regulatory scrutiny. Even after demonstrating promising results, however, a new treatment can face another formidable barrier: will a health system actually pay for it and make i...
Post a Comment
Read more

Cancer Treatment – Access is the Real Obstacle – Asrar Qureshi’s Blog Post #1312

Image
Cancer Treatment – Access is the Real Obstacle – Asrar Qureshi’s Blog Post #1312 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1312 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Ivan Samkov Preamble This post is based on a McKinsey article. The core McKinsey source is Bob Li's August 31, 2026 conversation, which outlines the MARS approach around next-generation evidence generation, community education, cancer networks, and international acceleration/collaboration. The wider cancer-burden figures and prevention/early-detection context come from WHO and IARC. Link at the end. Can We Eliminate Cancer? The Real Revolution May Be Access, Not Discovery Cancer has long been portrayed as an enemy that science must defeat through better drugs, better diagnostics and better technology. And there is good reason for th...
Post a Comment
Read more

Effect of Tobacco on Fertility – Asrar Qureshi’s Blog Post #1311

Image
Effect of Tobacco on Fertility – Asrar Qureshi’s Blog Post #1311 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1311 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Alex Zvir Preamble This blogpost takes some insights from a recent World Health Organization report. Link to the report at the end. Tobacco and Fertility: The Hidden Reproductive Cost of Smoking For decades, the dangers of tobacco have been associated primarily with cancer, heart disease, stroke and chronic respiratory illness. Yet a new warning from the World Health Organization (WHO) highlights another consequence that receives far less public attention: tobacco use can undermine fertility. The finding is important because infertility is already a major global health concern. WHO estimates that approximately one in six people of reproductive age ...
Post a Comment
Read more

Changing Demographic Trends and Development – Asrar Qureshi’s Blog Post #1310

Image
Changing Demographic Trends and Development – Asrar Qureshi’s Blog Post #1310 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1310 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Juan Philip Ramirez Credit: Rahul Varge Preamble This blogpost takes some insights from a recent article published in DevelopmentAid. Link to the article at the end. The Demographic Shift: What Changing Population Trends Mean for International Development For most of modern history, population growth was treated as one of the defining challenges of development. More people meant greater demand for food, housing, education, employment, healthcare and infrastructure. Governments and development agencies therefore focused heavily on managing rapid population growth and expanding services for growing populations. That picture is changing. ...
Post a Comment
Read more

Five Important Shifts in Consumer Behavior – Asrar Qureshi’s Blog Post #1309

Image
Five Important Shifts in Consumer Behavior – Asrar Qureshi’s Blog Post #1309 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1309 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: bi ravencrow Credit: Polina Tankilevitch Credit: Vitaly Gariev Preamble This blogpost takes insights from a recent Boston Consulting Group article. Link to the article at the end. The Consumer Has Changed: Five Shifts That Will Reshape Growth For decades, companies have built growth strategies around relatively familiar assumptions: consumers want lower prices, households are built around families, brands influence purchasing decisions, advertising creates awareness, and people make buying decisions largely on their own. Those assumptions are becoming less reliable. Consumers are changing not simply what they buy, but how they live, wha...
Post a Comment
Read more

Reckitt’s Strategic Reset – Asrar Qureshi’s Blog Post #1308

Image
Reckitt’s Strategic Reset – Asrar Qureshi’s Blog Post #1308 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1308 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Preamble This blogpost takes insights from a recent McKinsey article. Link to the article at the end. Reckitt is a British multinational consumer goods company headquartered in Slough, United Kingdom. It manufactures health and hygiene products. Reckitt's brands include the antiseptic brand Dettol, the sore throat medicine Strepsils, the toilet cleaner Harpic, the hair removal brand Veet, the cold, flu, and cough relief brand Mucinex, the indigestion remedy Gaviscon, the pain relief medication Nurofen and other brands and products like: Durex, Lysol, Finish, and Vanish. When Incremental Change Is Not Enough: Lessons from Reckitt’s Strategic Reset There comes a ...
Post a Comment
Read more